Home

Welcome to the Diabetes Research & Treatment Centre Inc. (DRTC)

Support for Diabetes research and education enhances care and quality of life.

Latest from the Blog

Leadership of DRTC
Members of the Board

President and Treasurer: Dr. Aubie Angel (Toronto)

Vice President and Secretary: Dr. Grant Pierce (Winnipeg)

Director: Dr. Naranjan Dhalla (Winnipeg)








New treatment for long COVID-19

A new clinical trial was recently published showing that Metformin, an inexpensive drug to treat Diabetes also prevents the development of long COVID-19 symptoms. In a long-term randomized control trial, Metformin taken for 2 weeks early in the development of SARS-CoV-2 prevents the development of symptoms of long COVID-19. This study was published in Lancet…

Promising New Drug to Prevent Type 1 Diabetes

FDA in the US has approved a drug that can delay the onset of Type 1 Diabetes. This new drug named teplizumab is not yet available on the market, but can delay the onset of Diabetes by an average of 2 years and in some cases, much longer up to 11 years. The drug is…

DRTC and Conference Sponsorship

DRTC has over the years promoted Diabetes research, education and treatment as a Sponsor of a variety of conferences in collaboration with many like-minded organizations, funders and research institutions. DRTC has partnered with many organizations including: Friends of CIHR, Canadian Academy of Health Sciences (CAHS), Banting Research Foundation (BRF), Royal Canadian Institute for the Advancement…

Get new content delivered directly to your inbox.